Friday, April 29, 2016| Latest E-book
Search results for Mylan Laboratories, Inc.

Showing of 1 - 10 from 17 results

Teva to buy Allergan generic business for $40.5 billion, drops <b>Mylan</b> bid | Reuters

Jul 28, 2015

Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters

economies of scale, crucial in the low-margin generic drugs business. Teva (TEVA.TA) (TEVA.N), which dropped its hostile pursuit of Myla
Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the g
India may take WTO action against EU over drug clinical trials - GVK | Reuters

Apr 15, 2015

India may take WTO action against EU over drug clinical trials - GVK | Reuters

precaution and there was no reason to suggest the drugs were ineffective or harmful.

The drugs suspended by the EMA include those made by U.S. fi

Wall St falls from latest records; auto sales soft

Mar 03, 2015

Wall St falls from latest records; auto sales soft

$48.13.

Mylan Inc fell 3.3 percent to $55.98. The generic drug maker gave its 2015 outlook and said it may look for another acquisit

FIPB clears 11 FDI proposals, refers Glenmark, Aurobindo deals to CCEA

Feb 20, 2015

FIPB clears 11 FDI proposals, refers Glenmark, Aurobindo deals to CCEA

in each of the proposal is above Rs 1,200 crore," the statement said.Besides, FIPB has deferred an investment proposal of Hyderabad- based Mylan Laboratories Limited for increase
All-stock deal: India's Strides Arcolab to buy Shasun Pharma for $200 mn

Sep 29, 2014

All-stock deal: India's Strides Arcolab to buy Shasun Pharma for $200 mn

statement.

In February last year, Strides sold its injectable drugs business to U.S. firm Mylan Inc for $1.6 billion.
#India
FIPB clears GSK's Rs 6,400 cr FDI proposal to hike stake in India

Jan 13, 2014

FIPB clears GSK's Rs 6,400 cr FDI proposal to hike stake in India

of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a subsidiary of Strides Arcolab.


#NewsTracker
Govt continues to allow 100% FDI in existing pharma firms

Jan 08, 2014

Govt continues to allow 100% FDI in existing pharma firms

government cleared the Rs 5,168-crore deal of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a subsidiary of Strides Arcolab.
#FDI